These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9564293)

  • 1. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival.
    Berney CR; Yang JL; Fisher RJ; Russell PJ; Crowe PJ
    World J Surg; 1998 May; 22(5):484-90. PubMed ID: 9564293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
    Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein markers in colorectal cancer: predictors of liver metastasis.
    Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
    Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer.
    Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
    Int J Cancer; 2000 Jan; 89(1):1-7. PubMed ID: 10719723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
    Kumar Dhar D; Kubota H; Tabara H; Kotoh T; Monden N; Igarashi M; Kohno H; Nagasue N
    Oncology; 1999; 56(2):122-8. PubMed ID: 9949298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer.
    Ichikawa W
    Pathobiology; 1994; 62(4):172-9. PubMed ID: 7537507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
    Cheah PY; Cao X; Eu KW; Seow-Choen F
    Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.
    Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H
    Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
    Tannapfel A; Köckerling F; Katalinic A; Wittekind C
    Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer.
    Katakura H; Tanaka F; Oyanagi H; Miyahara R; Yanagihara K; Otake Y; Wada H
    Ann Thorac Surg; 2002 Apr; 73(4):1060-4. PubMed ID: 11996241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
    Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
    Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival.
    Oliveira LA; Artigiani-Neto R; Waisberg DR; Fernandes LC; Lima Fde O; Waisberg J
    Arq Gastroenterol; 2010; 47(4):361-7. PubMed ID: 21225146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas.
    Ayhan A; Yasui W; Yokozaki H; Kitadai Y; Tahara E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):213-8. PubMed ID: 8099459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression.
    Indinnimeo M; Giarnieri E; Stazi A; Cicchini C; Brozzetti S; Valli C; Carreca I; Vecchione A
    Cancer Lett; 1997 Jan; 111(1-2):1-5. PubMed ID: 9022121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
    Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
    Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of nm23-H1 expression in colorectal carcinomas.
    Dursun A; Akyürek N; Günel N; Yamaç D
    Pathology; 2002 Oct; 34(5):427-32. PubMed ID: 12408341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.